Cote Elissa S. 4
4 · Vistagen Therapeutics, Inc. · Filed Apr 9, 2026
Research Summary
AI-generated summary of this filing
Vistagen (VTGN) Chief Corp Dev Officer Elissa Cote Receives 75,000 Options
What Happened Elissa S. Cote, Chief Corporate Development Officer of Vistagen Therapeutics (VTGN), received a grant of 75,000 stock options (reported as a derivative award) on April 7, 2026. The Form 4 lists the acquisition as 75,000 units at $0.00 because it records an option grant rather than an open-market stock purchase; the filing excerpt does not specify an exercise price or immediate cash value.
Key Details
- Transaction date: April 7, 2026; Form 4 filed April 9, 2026 (appears timely within the two-business-day reporting window).
- Reported transaction: Grant/award of 75,000 options (derivative); acquisition price shown as $0.00 on the Form 4.
- Vesting (per footnote): 25% vests six months after April 7, 2026 (Oct 7, 2026) and then in 25% installments every six months, fully vesting on April 7, 2028.
- Shares owned after transaction: not disclosed in the provided filing excerpt.
- No indication of a 10b5-1 plan, tax-withholding sale, or other special conditions in the excerpt.
Context This is a standard equity compensation award to an executive, not an open-market purchase or sale. Option grants are common as retention/incentive compensation and do not represent immediately tradable shares until vested and exercised. The filing does not state the option exercise price or whether any options were exercised or sold.
Insider Transaction Report
- Award
Incentive Stock Option (right to buy)
[F1]2026-04-07+75,000→ 75,000 totalExercise: $0.54Exp: 2036-04-07→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date.